| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/08/2009 | US7585676 Retroviral vector |
| 09/08/2009 | US7585675 Antisense IL-4 inhibits viral replication in the liver, lungs, spleen, and even the lymph nodes; can be used in combination with other antiretroviral agents or vaccines |
| 09/08/2009 | US7585673 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner |
| 09/08/2009 | US7585671 Hedgehog interacting proteins and uses related thereto |
| 09/08/2009 | US7585669 Genetic vaccine comprising an expression vector encoding a Streptococcus pneumoniae pneumolysin polypeptide that lacks hemolytic activity |
| 09/08/2009 | US7585668 Humanized immunoglobulin loci |
| 09/08/2009 | US7585667 Noncytopathic negative strand; synthetic respiratory syncytial virus (RSV) replicon; Noncytotoxic |
| 09/08/2009 | US7585666 genetically engineered chimeras comprising ligand binding domain fused to an effector domain of an apoptosis signaling molecule and second encoding a cis acting regulatory element; for use in/ex vivo |
| 09/08/2009 | US7585659 Carotene synthase gene and uses therefor |
| 09/08/2009 | US7585658 Staphylococcus aureus antigenic polypeptides and compositions |
| 09/08/2009 | US7585657 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells; hemagglutinin (HA) and neuraminidase (NA). |
| 09/08/2009 | US7585655 Nucleic acid encoding a fusion protein incorporating a cysteinized ribonuclease |
| 09/08/2009 | US7585654 Nucleic acid encoding cysteinized ribonuclease to which a targeting moiety can be conjugated |
| 09/08/2009 | US7585653 Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same |
| 09/08/2009 | US7585648 Nucleotide sequences coding myostatin epitopes for use in treatment and prevention of diabetic disorders; immunotherapy |
| 09/08/2009 | US7585646 Human GIL-19/AE289 polynucleotides and methods of producing the encoded polypeptides |
| 09/08/2009 | US7585645 Obtaining oil bodies from a cell; washing oil bodies to obtain a washed oil body preparation; formulating washed oil bodies with thioredoxin or thioredoxin reductase into an emulsion |
| 09/08/2009 | US7585635 Method for detecting and analyzing protein interactions in vivo |
| 09/08/2009 | US7585634 Using enhanced expression of lung gene (L-gene ) tumor antigen as diagnostic/evaluative tool in prediciting remission |
| 09/08/2009 | US7585631 for determining the presence of Cryptosporidium organisms in a test sample |
| 09/08/2009 | US7585625 Using solid carrier comprising immobilized probes to detect preferential gene sequences in nuclear extract; infection diagnosis |
| 09/08/2009 | US7585623 Syndrome X, metabolic syndrome, multiple risk factor syndrome, insulin resistant syndrome, deadly quartet, and visceral fat syndrome, diabetes, obesity, hypercholesterolemia, and hyperlipoproteinemias, hyperlipidemia, arteriosclerosis, hypertonia, circulatory system disease, hyperphagia |
| 09/08/2009 | US7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
| 09/08/2009 | US7585619 Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity |
| 09/08/2009 | US7585617 Method and device for thermal conditioning of a cell |
| 09/08/2009 | US7585522 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | US7585502 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunization |
| 09/08/2009 | US7585498 Recombinant Adenoviruses which function as helper viruses to gutted Ad viruses lacking viral coding sequences; gene therapy |
| 09/08/2009 | US7585497 Comprises nucleotide sequences coding insulin-like growth factor binding protein-3 and receptors for diagnosis, prevention and treatment of cancer; antitumor/anticarcinogenic agents |
| 09/08/2009 | US7585466 Measurements of the intensity of allele specific signals may be obtained and used to generate reaction values which may be compared to probability distributions in order to obtain conditional probabilities of genotypes of interest; genetic bit analysis (GBA) |
| 09/08/2009 | CA2372521C Mixed-bed solid phase and its use in the isolation of nucleic acids |
| 09/08/2009 | CA2355466C Multi-component vaccine comprising at least two antigens from haemophilus influenzae |
| 09/08/2009 | CA2294701C Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| 09/08/2009 | CA2281955C Ikb kinase, subunits thereof, and methods of using same |
| 09/08/2009 | CA2265505C An immune disease remedy, treatment method and preventive agent and method for dogs and cats |
| 09/08/2009 | CA2223678C Covalently linked oligonucleotide minor groove binder conjugates |
| 09/04/2009 | CA2658231A1 Method of producing recombinant tat-hoxb4h protein for use as a stimulant of hematopoiesis in vivo |
| 09/03/2009 | WO2009108898A2 Production and uses of type 1 ribosome inactivating proteins |
| 09/03/2009 | WO2009108891A2 Modified poloxamers for gene expression and associated methods |
| 09/03/2009 | WO2009108774A2 Use of synthetic scaffolds for the production of biosynthetic pathway products |
| 09/03/2009 | WO2009108693A2 Composition and methods for rapid detection of hiv by loop- mediated isothermal amplification (lamp) |
| 09/03/2009 | WO2009108689A1 Sugar glassified virus like particles (vlps) |
| 09/03/2009 | WO2009108389A1 Disease resistant transgenic plants |
| 09/03/2009 | WO2009108341A1 Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection |
| 09/03/2009 | WO2009108274A2 Methods and compositions for adeno-associated virus (aav) with hi loop mutations |
| 09/03/2009 | WO2009108217A2 Compositions comprising k-ras sirna and methods of use |
| 09/03/2009 | WO2009108021A2 Biomarker for diagnosing hyperpigmentation of skin |
| 09/03/2009 | WO2009107876A1 Probe reagent for measuring oxidative stress |
| 09/03/2009 | WO2009107822A1 Mutant gene capable of controlling the oil-and-fat content in seed, and method for controlling the oil-and-fat content in seed |
| 09/03/2009 | WO2009107821A1 Process for production of optically active carboxylic acid using esterase derived from thermophilic archaebacterium |
| 09/03/2009 | WO2009107820A1 Evaluation method for amount of fat and oil in seed and screening method for plant body with changed amount of fat and oil |
| 09/03/2009 | WO2009107816A1 Method for increasing enzymatic reactivity |
| 09/03/2009 | WO2009107803A1 Method for quantification of target substance |
| 09/03/2009 | WO2009107785A1 Marker for detection of il-17-producing helper t-cell, and method for detection of il-17-producing helper t-cell |
| 09/03/2009 | WO2009107775A1 Expression vector for mass production of foreign gene-derived protein using animal cell and use thereof |
| 09/03/2009 | WO2009107682A1 Polynucleotide encoding human-type fc receptor, and method for production of human-type fc receptor utilizing the same |
| 09/03/2009 | WO2009107631A1 Process for production of 5'-guanylic acid |
| 09/03/2009 | WO2009107170A1 Anti-crp antibody and utilization of the same |
| 09/03/2009 | WO2009107159A2 System for inducible gene expression in chlamydomonas |
| 09/03/2009 | WO2009106985A2 Biosynthetic engineering of glucosinolates |
| 09/03/2009 | WO2009106882A1 Cytochrome b5 knockout animal models |
| 09/03/2009 | WO2009106773A2 Transgenic non-human mammal for the constant region of the g-class human immunoglobulin heavy chain and applications thereof |
| 09/03/2009 | WO2009106668A1 Vectors and uses of the mboumar transposon |
| 09/03/2009 | WO2009106635A1 Expression system for proteins |
| 09/03/2009 | WO2009106596A2 Plants with increased yield |
| 09/03/2009 | WO2009106532A2 Use of prokaryotic tir-domain containing proteins as therapeutic and diagnostic agents |
| 09/03/2009 | WO2009106477A1 Microrna (mirna) and down-stream targets for diagnostic and therapeutic purposes |
| 09/03/2009 | WO2009106367A1 Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes |
| 09/03/2009 | WO2009106093A1 Methods for identifying one or more bioactive genes |
| 09/03/2009 | WO2009105934A1 Monoclonal antibody anti-human rankl |
| 09/03/2009 | WO2009105882A1 Stem cell expression cassettes |
| 09/03/2009 | WO2009105870A1 Genetically modified reduced-browning fruit-producing plant and produced fruit thereof, and method of obtaining such |
| 09/03/2009 | WO2009088735A3 Novel bacillus thuringiensis gene with coleopteran activity |
| 09/03/2009 | WO2009086229A3 Drought tolerant plants and related constructs and methods involving genes encoding mir827 |
| 09/03/2009 | WO2009085953A3 Ketol-acid reductoisomerase using nadh |
| 09/03/2009 | WO2009085216A3 Compositions and methods for detecting or elimninating senescent cells to diagnose or treat disease |
| 09/03/2009 | WO2009082085A3 Highly infectious nucleic acid molecules from pepper mottle virus and plant viral vector derived from the same |
| 09/03/2009 | WO2009076539A3 Modulation of protein degradation and uses thereof |
| 09/03/2009 | WO2009073905A8 Method for increasing immunoreactivity |
| 09/03/2009 | WO2009072835A3 Transgenic cats expressing red fluorescence protein and producing method thereof |
| 09/03/2009 | WO2009069935A3 Pharmaceutical compositions and methods for delivering nucleic acids into cells |
| 09/03/2009 | WO2009068313A3 Brassica plant comprising a mutant indehiscent allele |
| 09/03/2009 | WO2009064777A3 Production of fc-fusion polypeptides in eukaryotic algae |
| 09/03/2009 | WO2009064590A3 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer |
| 09/03/2009 | WO2009063426A3 Mirna, sirna and use thereof in therapy |
| 09/03/2009 | WO2009061380A3 VARIANTS OF BACILLUS sup. TS-23 ALPHA-AMYLASE WITH ALTERED PROPERTIES |
| 09/03/2009 | WO2009061369A3 Directed evolution using proteins comprising unnatural amino acids |
| 09/03/2009 | WO2009059804A3 T-cell receptor peptides specific for part of cd20, uses thereof, and methods of preparing cytotoxic t-cells |
| 09/03/2009 | WO2009053104A3 Viral vector system, a composition comprising the viral vector system and its use |
| 09/03/2009 | WO2009048537A3 Humanized antibody |
| 09/03/2009 | WO2009030440A3 Sidna against hepatitis c virus (hcv) |
| 09/03/2009 | WO2009020848A3 RNAI-RELATED INHIBITION OF TNFα SIGNALING PATHWAY FOR TREATMENT OF GLAUCOMA |
| 09/03/2009 | WO2009003429A3 Method of regulation of biomass production in plants, dna sequences and method of preparation thereof |
| 09/03/2009 | WO2008121008A8 Control of plant gene expression |
| 09/03/2009 | WO2008047006A9 Polynucleotides and polypeptides coded by said polynucleotides involved in the biosynthesis of congocidine and derivatives thereof |
| 09/03/2009 | US20090222955 Delta 6 desaturases from primulaceae, expressing plants and pufa-containing oils |
| 09/03/2009 | US20090222954 Maize Genes For Controlling Plant Growth and Organ Size and Their Use in Improving Crop Plants |
| 09/03/2009 | US20090222953 Mutated plant and method for production thereof |
| 09/03/2009 | US20090222952 Plants Having Improved Growth Characteristics And A Method For Making The Same |